IMCR241220C45000
- 2.55
- 0.000.00%
Immunocore Newsroom
Goldman Sachs Maintains Immunocore(IMCR.US) With Buy Rating, Announces Target Price $74
Immunocore Hldgs Analyst Ratings
Mizuho Securities Downgrades Immunocore(IMCR.US) to Hold Rating, Cuts Target Price to $38
Morgan Stanley Maintains Immunocore(IMCR.US) With Buy Rating, Maintains Target Price $74
H.C. Wainwright Maintains Immunocore(IMCR.US) With Buy Rating, Maintains Target Price $100
Oppenheimer Trims Immunocore Price Target to $88 From $89, Maintains Outperform Rating
Barclays Maintains Immunocore(IMCR.US) With Buy Rating, Maintains Target Price $66
Barclays Keeps Their Buy Rating on Immunocore Holdings (IMCR)
Needham Maintains Immunocore(IMCR.US) With Buy Rating, Cuts Target Price to $71
TD Cowen Maintains Immunocore(IMCR.US) With Buy Rating, Cuts Target Price to $60
Immunocore Holdings: Strong Market Performance and Promising Pipeline Drive Buy Rating
UBS Initiates Coverage On Immunocore Hldgs With Sell Rating, Announces Price Target of $24
H.C. Wainwright Maintains Immunocore(IMCR.US) With Buy Rating, Maintains Target Price $100
Immunocore Holdings Is Maintained at Overweight by Morgan Stanley
Morgan Stanley Maintains Immunocore(IMCR.US) With Buy Rating, Cuts Target Price to $74
Immunocore Hldgs Analyst Ratings
Capital One Financial Maintains Immunocore(IMCR.US) With Buy Rating, Maintains Target Price $90
Guggenheim Downgrades Immunocore(IMCR.US) to Hold Rating
巴克莱银行维持Immunocore(IMCR.US)买入评级，维持目标价66美元
Barclays Gives a Buy Rating to Immunocore Holdings (IMCR)